Chang Elisabeth Dohmann, Owen Stewart F, Hogstrand Christer, Bury Nic R
King's College London, Division of Diabetes and Nutritional Sciences, Franklin Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
Anal Methods. 2021 Mar 28;13(12):1470-1478. doi: 10.1039/d0ay02282a. Epub 2021 Mar 8.
Advances in analytical methods have enabled the detection of emerging contaminants at ever lower concentrations in freshwaters. However, such measurements need to be linked to effect-based assays to identify risks. The bioconcentration factor (BCF) forms part of a chemical's environmental risk assessment (ERA), and current regulatory testing guidelines to calculate fish BCFs use hundreds of fish per chemical. Due to ethical concerns a reduction in the numbers of animals used is desired, and there is a need to identify in vitro or in silico alternatives which meet regulatory acceptance. This study describes the successful demonstration of a FIsh Gill Cell culture System (FIGCS) to assess an often overlooked parameter in pharmacokinetics: the excretion of drugs across the gill. The FIGCS tolerates the application of natural waters on its apical surface, mimicking the situation of the live fish, and thus in combination with advanced analytical methods, offers an opportunity to take lab-based testing used for ERA, such as compound uptake, biotransformation or excretion directly into field for validation with natural waters. Here we used the basic drug propranolol and the acidic ibuprofen as a demonstration of the FIGCS utility in three separate experiments. Excretion across the apical membrane showed saturation kinetics, suggesting the involvement of carrier-mediated processes. Both propranolol and ibuprofen were excreted across the epithelium from the media (internal blood equivalent) to the water, with ibuprofen excretion being considerably slower than propranolol excretion. Further studies indicate that ibuprofen may be complexing with fetal bovine serum (FBS) reducing bioavailability; in contrast propranolol efflux rate was unaffected, indicating that drugs behave differently in the presence of FBS and other plasma proteins. A key issue in future ERA is to better understand the effects of mixtures of different pollutant classes found in environmental samples, and this model offers an ethical path to do this.
分析方法的进步使得在淡水中能够检测到浓度越来越低的新型污染物。然而,此类测量需要与基于效应的检测方法相结合,以识别风险。生物富集因子(BCF)是化学品环境风险评估(ERA)的一部分,目前计算鱼类BCF的监管测试指南针对每种化学品要使用数百条鱼。出于伦理方面的考虑,人们希望减少动物的使用数量,因此需要确定符合监管要求的体外或计算机模拟替代方法。本研究描述了鱼类鳃细胞培养系统(FIGCS)的成功示范,该系统用于评估药物代谢动力学中一个常被忽视的参数:药物通过鳃的排泄。FIGCS能够耐受在其顶端表面施加天然水,模拟活鱼的情况,因此与先进的分析方法相结合,为将用于ERA的实验室检测(如化合物摄取、生物转化或排泄)直接应用于现场并用天然水进行验证提供了机会。在这里,我们使用基本药物普萘洛尔和酸性药物布洛芬在三个独立实验中证明了FIGCS的效用。通过顶端膜的排泄呈现饱和动力学,表明存在载体介导的过程。普萘洛尔和布洛芬都从培养基(内部血液等效物)通过上皮细胞排泄到水中,布洛芬的排泄比普萘洛尔的排泄慢得多。进一步的研究表明,布洛芬可能与胎牛血清(FBS)结合,从而降低生物利用度;相比之下,普萘洛尔的外排速率不受影响,这表明药物在FBS和其他血浆蛋白存在的情况下表现不同。未来ERA的一个关键问题是更好地了解环境样品中不同污染物类别的混合物的影响,而该模型提供了一条符合伦理的途径来实现这一点。